These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 32342521)

  • 1. Reducing the red blood cell transfusion threshold from 8·0 g/dl to 7·0 g/dl in acute myeloid leukaemia patients undergoing induction chemotherapy reduces transfusion rates without adversely affecting patient outcome.
    Ballo O; Fleckenstein P; Eladly F; Kreisel EM; Stratmann J; Seifried E; Müller M; Serve H; Bug G; Bonig H; Brandts CH; Finkelmeier F
    Vox Sang; 2020 Oct; 115(7):570-578. PubMed ID: 32342521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restrictive versus liberal red blood cell transfusion strategies for people with haematological malignancies treated with intensive chemotherapy or radiotherapy, or both, with or without haematopoietic stem cell support.
    Estcourt LJ; Malouf R; Trivella M; Fergusson DA; Hopewell S; Murphy MF
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD011305. PubMed ID: 28128441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transfusion thresholds for guiding red blood cell transfusion.
    Carson JL; Stanworth SJ; Dennis JA; Trivella M; Roubinian N; Fergusson DA; Triulzi D; Dorée C; Hébert PC
    Cochrane Database Syst Rev; 2021 Dec; 12(12):CD002042. PubMed ID: 34932836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion.
    Carson JL; Stanworth SJ; Roubinian N; Fergusson DA; Triulzi D; Doree C; Hebert PC
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD002042. PubMed ID: 27731885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benefits and harms of red blood cell transfusions in patients with septic shock in the intensive care unit.
    Holst LB
    Dan Med J; 2016 Feb; 63(2):. PubMed ID: 26836806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility of a restrictive red-cell transfusion policy for patients treated with intensive chemotherapy for acute myeloid leukaemia.
    Jansen AJ; Caljouw MA; Hop WC; van Rhenen DJ; Schipperus MR
    Transfus Med; 2004 Feb; 14(1):33-8. PubMed ID: 15043591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multicentre randomised controlled trial of Transfusion Indication Threshold Reduction on transfusion rates, morbidity and health-care resource use following cardiac surgery (TITRe2).
    Reeves BC; Pike K; Rogers CA; Brierley RC; Stokes EA; Wordsworth S; Nash RL; Miles A; Mumford AD; Cohen A; Angelini GD; Murphy GJ
    Health Technol Assess; 2016 Aug; 20(60):1-260. PubMed ID: 27527344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Practice Guidelines From the AABB: Red Blood Cell Transfusion Thresholds and Storage.
    Carson JL; Guyatt G; Heddle NM; Grossman BJ; Cohn CS; Fung MK; Gernsheimer T; Holcomb JB; Kaplan LJ; Katz LM; Peterson N; Ramsey G; Rao SV; Roback JD; Shander A; Tobian AA
    JAMA; 2016 Nov; 316(19):2025-2035. PubMed ID: 27732721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liberal Versus Restrictive Red Blood Cell Transfusion Thresholds in Hematopoietic Cell Transplantation: A Randomized, Open Label, Phase III, Noninferiority Trial.
    Tay J; Allan DS; Chatelain E; Coyle D; Elemary M; Fulford A; Petrcich W; Ramsay T; Walker I; Xenocostas A; Tinmouth A; Fergusson D
    J Clin Oncol; 2020 May; 38(13):1463-1473. PubMed ID: 32083994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liberal transfusion strategy to prevent mortality and anaemia-associated, ischaemic events in elderly non-cardiac surgical patients - the study design of the LIBERAL-Trial.
    Meybohm P; Lindau S; Treskatsch S; Francis R; Spies C; Velten M; Wittmann M; Gueresir E; Stoppe C; Kowark A; Coburn M; Selleng S; Baschin M; Jenichen G; Meersch M; Ermert T; Zarbock A; Kranke P; Kredel M; Helf A; Laufenberg-Feldmann R; Ferner M; Wittenmeier E; Gürtler KH; Kienbaum P; de Abreu MG; Sander M; Bauer M; Seyfried T; Gruenewald M; Choorapoikayil S; Mueller MM; Seifried E; Brosteanu O; Bogatsch H; Hasenclever D; Zacharowski K;
    Trials; 2019 Feb; 20(1):101. PubMed ID: 30717805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pilot randomized study for optimal red cell transfusion in acute myeloid leukemia patients with intensive chemotherapy.
    Byun JM; Park W; Shin DY; Koh Y; Kim I; Yoon SS; Park JH; Kim H; Hong J
    Blood Transfus; 2023 Nov; 21(6):479-487. PubMed ID: 37235735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized trial of liberal versus restrictive guidelines for red blood cell transfusion in preterm infants.
    Bell EF; Strauss RG; Widness JA; Mahoney LT; Mock DM; Seward VJ; Cress GA; Johnson KJ; Kromer IJ; Zimmerman MB
    Pediatrics; 2005 Jun; 115(6):1685-91. PubMed ID: 15930233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restrictive versus liberal blood transfusion for acute upper gastrointestinal bleeding (TRIGGER): a pragmatic, open-label, cluster randomised feasibility trial.
    Jairath V; Kahan BC; Gray A; Doré CJ; Mora A; James MW; Stanley AJ; Everett SM; Bailey AA; Dallal H; Greenaway J; Le Jeune I; Darwent M; Church N; Reckless I; Hodge R; Dyer C; Meredith S; Llewelyn C; Palmer KR; Logan RF; Travis SP; Walsh TS; Murphy MF
    Lancet; 2015 Jul; 386(9989):137-44. PubMed ID: 25956718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is haemoglobin below 7.0 g/dL an optimal trigger for allogenic red blood cell transfusion in patients admitted to intensive care units? A meta-analysis and systematic review.
    Yao RQ; Ren C; Zhang ZC; Zhu YB; Xia ZF; Yao YM
    BMJ Open; 2020 Feb; 10(2):e030854. PubMed ID: 32029484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of a Restrictive versus Liberal Approach to Red Blood Cell Transfusion on the Outcome of AKI in Patients Undergoing Cardiac Surgery: A Randomized Clinical Trial.
    Garg AX; Badner N; Bagshaw SM; Cuerden MS; Fergusson DA; Gregory AJ; Hall J; Hare GMT; Khanykin B; McGuinness S; Parikh CR; Roshanov PS; Shehata N; Sontrop JM; Syed S; Tagarakis GI; Thorpe KE; Verma S; Wald R; Whitlock RP; Mazer CD;
    J Am Soc Nephrol; 2019 Jul; 30(7):1294-1304. PubMed ID: 31221679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adherence to a restrictive red blood cell transfusion strategy in critically ill patients: An observational study.
    Bjurström MF; Linder YC; Kjeldsen-Kragh J; Bengtsson J; Kander T
    Acta Anaesthesiol Scand; 2024 Jul; 68(6):812-820. PubMed ID: 38453453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Red blood cell utilization and transfusion triggers in patients diagnosed with chronic lymphocytic leukaemia in Iceland 2003-2016.
    Thorvaldsson HH; Vidarsson B; Sveinsdottir SV; Olafsson GB; Halldorsdottir AM
    Vox Sang; 2019 Jul; 114(5):495-504. PubMed ID: 30972770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The best strategy for red blood cell transfusion in severe burn patients, restrictive or liberal: A randomized controlled trial.
    Salehi SH; Daniali M; Motaghi P; Momeni M
    Burns; 2021 Aug; 47(5):1038-1044. PubMed ID: 34045114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methodologic quality assessment of red blood cell transfusion guidelines and the evidence base of more restrictive transfusion thresholds.
    Van Remoortel H; De Buck E; Dieltjens T; Pauwels NS; Compernolle V; Vandekerckhove P
    Transfusion; 2016 Feb; 56(2):472-80. PubMed ID: 26545702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion.
    Carless PA; Henry DA; Carson JL; Hebert PP; McClelland B; Ker K
    Cochrane Database Syst Rev; 2010 Oct; (10):CD002042. PubMed ID: 20927728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.